Chemotherapy Options for Locally Advanced Gastric Cancer: A Review.

Cancers (Basel) · 2025 · PMC11899121 · PMID 40075656

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The DOS regimen demonstrated better pathological response and showed a trend toward longer 3-year progression-free survival and 3-year overall survival, with a comparable safety profile to the SOX regimen [ 61 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.